Body mass index and risk for end-stage renal disease
- PMID: 16389251
- DOI: 10.7326/0003-4819-144-1-200601030-00006
Body mass index and risk for end-stage renal disease
Abstract
Background: Although interest in the relationship between obesity and kidney disease is increasing, few epidemiologic studies have examined whether excess weight is an independent risk factor for end-stage renal disease (ESRD).
Objective: To determine the association between increased body mass index (BMI) and risk for ESRD.
Design: Historical (nonconcurrent) cohort study.
Setting: A large integrated health care delivery system in northern California.
Participants: 320,252 adult members of Kaiser Permanente who volunteered for screening health checkups between 1964 and 1985 and who had height and weight measured.
Measurements: The authors ascertained ESRD cases by matching data with the U.S. Renal Data System registry through 2000.
Results: A total of 1471 cases of ESRD occurred during 8,347,955 person-years of follow-up. Higher BMI was a risk factor for ESRD in multivariable models that adjusted for age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level. Compared with persons who had normal weight (BMI, 18.5 to 24.9 kg/m2), the adjusted relative risk for ESRD was 1.87 (95% CI, 1.64 to 2.14) for those who were overweight (BMI, 25.0 to 29.9 kg/m2), 3.57 (CI, 3.05 to 4.18) for those with class I obesity (BMI, 30.0 to 34.9 kg/m2), 6.12 (CI, 4.97 to 7.54) for those with class II obesity (BMI, 35.0 to 39.9 kg/m2), and 7.07 (CI, 5.37 to 9.31) for those with extreme obesity (BMI > or = 40 kg/m2). Higher baseline BMI remained an independent predictor for ESRD after additional adjustments for baseline blood pressure level and presence or absence of diabetes mellitus.
Limitations: Primary analyses were based on single measurements of exposures.
Conclusions: High BMI is a common, strong, and potentially modifiable risk factor for ESRD.
Comment in
-
Being overweight or obese was associated with a greater risk for end-stage renal disease.ACP J Club. 2006 May-Jun;144(3):78. ACP J Club. 2006. PMID: 16646622 No abstract available.
-
Body mass index and risk for end-stage renal disease.Ann Intern Med. 2006 May 2;144(9):700-1; author reply 701-2. doi: 10.7326/0003-4819-144-9-200605020-00020. Ann Intern Med. 2006. PMID: 16670145 No abstract available.
-
Body mass index and risk for end-stage renal disease.Ann Intern Med. 2006 May 2;144(9):701; author reply 701-2. doi: 10.7326/0003-4819-144-9-200605020-00021. Ann Intern Med. 2006. PMID: 16670146 No abstract available.
Summary for patients in
-
Summaries for patients. Are overweight or obese people at greater risk for kidney failure?Ann Intern Med. 2006 Jan 3;144(1):I28. doi: 10.7326/0003-4819-144-1-200601030-00002. Ann Intern Med. 2006. PMID: 16389247 No abstract available.
Similar articles
-
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.Arch Intern Med. 2005 Apr 25;165(8):923-8. doi: 10.1001/archinte.165.8.923. Arch Intern Med. 2005. PMID: 15851645
-
Risk factors for end-stage renal disease: 25-year follow-up.Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605. Arch Intern Med. 2009. PMID: 19237717 Free PMC article.
-
Body mass index in 1.2 million adolescents and risk for end-stage renal disease.Arch Intern Med. 2012 Nov 26;172(21):1644-50. doi: 10.1001/2013.jamainternmed.85. Arch Intern Med. 2012. PMID: 23108588 Free PMC article.
-
Predictors of diabetic end-stage renal disease in Japan.Nephrology (Carlton). 2005 Oct;10 Suppl:S2-6. doi: 10.1111/j.1440-1797.2005.00447.x. Nephrology (Carlton). 2005. PMID: 16174282 Review.
-
Screening and Interventions for Childhood Overweight [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. PMID: 20722132 Free Books & Documents. Review.
Cited by
-
Obesity-related renal dysfunction: gender-specific influence of visceral adiposity and early impact of metabolic and bariatric surgery.Front Endocrinol (Lausanne). 2024 Oct 14;15:1440250. doi: 10.3389/fendo.2024.1440250. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39469576 Free PMC article.
-
Endoplasmic reticulum stress induces renal fibrosis in high‑fat diet mice via the TGF‑β/SMAD pathway.Mol Med Rep. 2024 Dec;30(6):235. doi: 10.3892/mmr.2024.13360. Epub 2024 Oct 18. Mol Med Rep. 2024. PMID: 39422027 Free PMC article.
-
New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy.Drug Des Devel Ther. 2024 Sep 23;18:4257-4272. doi: 10.2147/DDDT.S476815. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39347536 Free PMC article. Review.
-
Association of obesity severity and duration with incidence of chronic kidney disease.BMC Nephrol. 2024 Sep 27;25(1):320. doi: 10.1186/s12882-024-03757-x. BMC Nephrol. 2024. PMID: 39333911 Free PMC article.
-
The systemic inflammatory response index is associated with chronic kidney disease in patients with hypertension: data from the national health and nutrition examination study 1999-2018.Ren Fail. 2024 Dec;46(2):2396459. doi: 10.1080/0886022X.2024.2396459. Epub 2024 Sep 23. Ren Fail. 2024. PMID: 39311633 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical